BerandaSNPHF • OTCMKTS
add
Santen Pharmaceutical Co Ltd
Tutup sebelumnya
$11,45
Rentang tahun
$9,80 - $12,46
Kapitalisasi pasar
572,44Â M JPY
Volume Rata-Rata
57,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
TYO
Berita pasar
FXStreet
2 hari yang lalu
Dow Jones Industrial Average naik 360 poin setelah NFP Mengalahkan Prakiraan
0,83%
0,77%
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (JPY) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 77,23Â M | -2,40% |
Biaya operasional | 32,01Â M | 1,78% |
Laba bersih | 8,79Â M | 30.213,79% |
Margin laba bersih | — | — |
Penghasilan per saham | — | — |
EBITDA | 18,48Â M | -10,21% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (JPY) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 93,00Â M | -1,68% |
Total aset | 409,28Â M | -6,06% |
Total liabilitas | 124,10Â M | -4,78% |
Total ekuitas | 285,18 M | — |
Saham yang beredar | 341,36 jt | — |
Harga terhadap nilai buku | 0,01 | — |
Tingkat pengembalian aset | 8,72% | — |
Tingkat pengembalian modal | 12,39% | — |
Arus Kas
Perubahan kas bersih
| (JPY) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 8,79Â M | 30.213,79% |
Kas dari operasi | 18,89Â M | 43,01% |
Kas dari investasi | -976,00Â jt | -134,62% |
Kas dari pembiayaan | -861,00Â jt | 68,24% |
Perubahan kas bersih | 15,15Â M | 20,67% |
Arus kas bebas | 13,86Â M | 34,37% |
Tentang
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
Didirikan
1890
Kantor pusat
Situs
Karyawan
3.849
